Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 67.47B | 61.84B | 54.61B | 44.61B | 38.25B |
Gross Profit | 40.22B | 36.40B | 31.06B | 25.65B | 22.63B |
EBITDA | 8.63B | 6.87B | 3.66B | 3.70B | 1.41B |
Net Income | 4.96B | 3.26B | 1.01B | 1.30B | -443.06M |
Balance Sheet | |||||
Total Assets | 34.81B | 32.77B | 30.76B | 26.91B | 23.94B |
Cash, Cash Equivalents and Short-Term Investments | 11.95B | 10.55B | 7.69B | 7.00B | 5.26B |
Total Debt | 8.20B | 10.12B | 12.38B | 11.15B | 10.36B |
Total Liabilities | 17.75B | 19.24B | 20.46B | 17.61B | 15.85B |
Stockholders Equity | 17.06B | 13.54B | 10.30B | 9.30B | 8.10B |
Cash Flow | |||||
Free Cash Flow | 4.92B | 5.09B | 2.67B | 2.59B | 45.12M |
Operating Cash Flow | 6.79B | 6.22B | 4.68B | 4.03B | 1.60B |
Investing Cash Flow | -1.77B | -906.26M | -2.19B | -1.85B | -2.08B |
Financing Cash Flow | -3.58B | -2.60B | -1.86B | -509.25M | 2.22B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥71.99B | 14.47 | 1.97% | 9.11% | 52.03% | ||
71 Outperform | ¥67.00B | 21.16 | 1.51% | 0.46% | 626.15% | ||
69 Neutral | ¥114.40B | 36.34 | 0.81% | 3.36% | 22.37% | ||
69 Neutral | ¥74.50B | 72.20 | 0.33% | 1.40% | -26.08% | ||
67 Neutral | ¥56.69B | 59.12 | 0.45% | 8.92% | 28.78% | ||
66 Neutral | £1.86B | 11.36 | 6.20% | 3.10% | 0.61% | -17.57% | |
64 Neutral | ¥137.81B | 112.01 | 0.57% | 4.82% | -79.12% |